SCHEMBL4335524

SCHEMBL4335524

COc1ccc2c(c1)C(Cc1ccccc1)[C@@]1(CCNC(=O)C1)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.40
SIGMAR1 Q99720 5/20 0.38
HTR1A P08908 2/20 0.38
OPRK1 P41145 2/20 0.38
ADRB2 P07550 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
HRH1 P35367 1/20 0.38
OPRM1 P35372 1/20 0.38
HTR2B P41595 1/20 0.38
HTR5A P47898 1/20 0.38
SLC6A3 Q01959 1/20 0.38
CYP19A1 P11511 3/20 0.37
HTR2A P28223 1/20 0.37
BCHE P06276 1/20 0.36
CYP24A1 Q07973 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4484620 0.80 HTR2A (0.41) ARSIGMAR1HTR1AOPRK1ADRB2
SCHEMBL24879518 0.72 HTR2C (0.56) SIGMAR1HTR1AOPRK1ADRB2ADRA2A
SCHEMBL14151107 0.69 HTR2A (0.46) ARSIGMAR1HTR1AHTR2CHTR2B
SCHEMBL13736116 0.68 TACR2 (0.46) ARSIGMAR1HTR1AHTR2CHTR2B
SCHEMBL22303469 0.67 HTR2C (0.46) SIGMAR1HTR1AOPRK1ADRB2ADRA2A
SCHEMBL23987135 0.67 HTR2C (0.46) SIGMAR1HTR1AOPRK1ADRB2ADRA2A
SCHEMBL606089 0.67 HTR2A (0.56) ARSIGMAR1HTR1ACYP19A1HTR2A
SCHEMBL4564958 0.67 HRH1 (0.50) HTR1ASLC6A2HTR2CHRH1HTR2B
SCHEMBL10348907 0.66 SLC22A1 (0.63) ADRB2BCHE
SCHEMBL6826968 0.66 HTR2A (0.50) ARSIGMAR1HTR1ACYP19A1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009039431-A2 SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINES NEUROGEN CORPORATION (US) 2009-03-26 WO disclosed